Biofeedback Instrument Market Forecast 2023 - 2030

By Type :

The product type segment is categorized into electromyography (EMG), electroencephalogram (EEG), thermal feedback, heart rate variability feedback, electrodermal activity feedback, and others. In 2022, the electromyography (EMG) segment accounted for the highest market share and is expected to be the fastest-growing segment during the forecast period. Electromyography (EMG) involves the measurement and feedback of electrical activity produced by muscles. It is commonly used in rehabilitation, sports training, and stress management. Electromyography (EMG) feedback helps individuals improve muscle control, reduce muscle tension, and enhance overall physical instruments is significant, especially in the fields of physical therapy, sports medicine, and performance training. For instance, in 2020, MyoTrac Infinity by Thought Technology Ltd developed an EMG biofeedback device that offers comprehensive muscle activity monitoring and training capabilities. The system includes various sensors and electrodes for measuring muscle tension and providing real-time feedback to users. The development of a new product range and others are prime factors accelerating the growth of the electromyography (EMG) segment.

By Application :

The application segment is categorized into brain waves, heart rate and blood pressure, muscle tension, sweat glands, and others. In 2022, the brain waves segment accounted for the highest market share and is expected to be the fastest-growing segment during the forecast period. Brain waves focus on measuring and providing feedback on the electrical activity of the brain and it is widely used in mental health, neuro therapy, meditation training, and cognitive enhancement.

For instance, in 2020, according to the World Health Organization (WHO), globally, more than 264 million people suffer from depression, and around 284 million people have an anxiety disorder. Furthermore, the demand for brain wave biofeedback instruments is propelled by a wide range of organizations and individuals seeking to optimize brain function, improve meant health, enhance performance, and promote well-being.

By End-Use :

The end-use type segment is categorized into hospitals, clinics, rehabilitation centers, and others. In 2022, the hospital segment accounted for the highest market share of 48.15% in the biofeedback instrument market. Biofeedback instrument in hospital is influenced by several factors including government initiative promoting integrative and holistic approaches to healthcare, increasing patient awareness and demand for non-pharmacological intervention supporting the efficacy of biofeedback in various medical application.

However, rehabilitation centre segment is expected to be the fastest-growing segment in the biofeedback instrument market during the forecast period. This is due to government initiatives, developing guidelines, and spending on research to promote the use of biofeedback instruments in rehabilitation centre.

Get More Information

Download Sample Report

By Region :

The regional segment includes North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

In 2022, North America accounted for the highest market share at 38.50% and was valued at USD 67.61 million, and is expected to reach USD 109.22 million in 2030. In North America, the U.S. accounted for the highest market share of 68.35% during the base year of 2022. This is due to the launch of a new range of upgraded biofeedback instruments in the North American region, a well-established healthcare system, high healthcare expenditure, and increasing awareness and acceptance of therapies.

Furthermore, Asia Pacific is expected to witness significant growth over the forecast period, growing at a CAGR of 6.7% during 2023-20230. This is attributed to the large population base, and rising awareness about therapies in countries such as China, and India.